RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Accelerated Approval and Priority Review. The WHO trial and decision to stop the trial was based on treating already-hospitalized patients. HCQ's efficacy is best when used as a prophylactic or during the first five days following exposure during incubation and prior to hospitalization, and also with zinc which prevents the rapid multiplication of the virus in the patient's cells, as well as with a suitable antibiotic to control other bacterial infection.
Nothing hard to understand or inconsistent. If you check the premises and compare the results, the comparison is between early use of HCQ and later use of HCQ. The results they're seeing are the same that have been seen since early in this epidemic.
Use HCQ early to prevent the virus multiplying. Once it gets into the cells and multiplies, it's time for a different treatment regimen. Use other meds to treat after a patient is hospitalized. The WHO trial results confirm this, as expected. Politics and media have distorted the arguments to suit their own desires.